Discovery Platform
From Target to Market

Discovery Services

Proven Chemistry

Screening Libraries
1.6M Compounds eShop

Pharmaceutical
Development

Pharmaceutical Development

Why Choose ChemDiv?

  • 25 years experience and 2500 customers worldwide
  • Premium R&D CRO based in USA with global reach
  • Seasoned project managers
  • Extensive Academic partnerships
  • Flexible business models
  • Industry's largest ever-greening stock compound inventory
  • Ongoing investments in novel proprietary chemistry and discovery platforms
Learn More About Us

Our News

Viriom Signed Licensing Agreement for Indonesia with P.T. Lloyd Pharma
Meet ChemDiv at “Better Leads, Better Drugs – Innovation in Screening Libraries”
Viriom China Wins Award at 2018 Zhongguancun International Frontier Science and Technology Innovation Competition
Read All Our News >

Pharma News

US and EU enter Mutual Recognition Agreement for drug manufacturing inspections
Gilead invests $5 billion to deepen ties with biotech Galapagos
Evoke taps new president for North America, continues talent expansion
Read All Pharma News >

New Products &Services

Target Activity profiling library
MCE-18 Trends in MedChem
Covalent Inhibitors library
RNA Trinucleotide mimetics
Share this: